ARCHIVES

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 24 No. 40 | October 23, 1998

Download PDF Visit The Full Archive

Related Articles

Army Breast Cancer Program Seeks Grants Applicants

May 17, 1996

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012